Markus Leo
6PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 16, 2026
Choosing the optimal mouse model for the study of late-onset spinal muscular atrophy: Why the 4-copy SMN2 model offers ideal translational relevance.Markus Leo, Linda-Isabell Schmitt, Kai Christine Liebig
|Dec 10, 2025
Targeting Astrocytic Connexin 43 Mitigates Glutamate-Driven Motor Neuron Stress in Late-Onset Spinal Muscular Atrophy.Schahin Salmanian, Linda-Isabell Schmitt, Kai Christine Liebig
|Aug 28, 2025
Neuronal Pentraxin 2 as a Potential Biomarker for Nusinersen Therapy Response in Adults with Spinal Muscular Atrophy: A Pilot Study.Svenja Neuhoff, Linda-Isabell Schmitt, Kai Christine Liebig
|Oct 13, 2023
Analysis of Free Circulating Messenger Ribonucleic Acids in Serum Samples from Late-Onset Spinal Muscular Atrophy Patients Using nCounter NanoString Technology.Markus Leo, Linda-Isabell Schmitt, Fabian Mairinger
|Aug 09, 2022
Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular Atrophy.Benjamin Stolte, Olivia Schreiber-Katz, René Günther
|Feb 15, 2022
Induction of Survival of Motor Neuron (SMN) Protein Deficiency in Spinal Astrocytes by Small Interfering RNA as an In Vitro Model of Spinal Muscular Atrophy.Markus Leo, Linda-Isabell Schmitt, Michael Fleischer
Pageof 1
Frequent Collaborators
6 joint publications
Tim Hagenacker
5 joint publications
Christoph Kleinschnitz
3 joint publications
Kai Christine Liebig
3 joint publications
Andreas Roos
1 joint publications
Benjamin Stolte
1 joint publications
Olivia Schreiber-Katz
1 joint publications
René Günther
1 joint publications
Claudia Diana Wurster
1 joint publications
Susanne Petri
1 joint publications
Peter Claus
